PERJETA
PERJETA
Approved
DIN Number
02405016
Drug Class
Human
Market Date
May 8, 2013
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02405016
AIG Number0154250001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FD02 PERTUZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PERTUZUMABActive
Strength: 420 MG / 14 ML
Monograph: PERTUZUMAB